Literature DB >> 2170712

The 5'-terminal sequence of the hepatitis C virus genome.

H Okamoto1, S Okada, Y Sugiyama, S Yotsumoto, T Tanaka, H Yoshizawa, F Tsuda, Y Miyakawa, M Mayumi.   

Abstract

The 5'-terminal sequence of the genome of hepatitis C virus (HCV) was determined for two distinct HCV strains in human and chimpanzee carriers. It had a 5'-noncoding region of at least 324 nucleotides, well preserved by the two strains with a high homology (99.1%), followed by 1348 nucleotides that continued to the documented sequence of prototype HCV spanning 7310 nucleotides (European Patent Application #88310922.5). Based on these results, HCV is considered to possess an uninterrupted open reading frame encoding at least 2886 amino acid residues. Two structural genes were postulated on the 5'-terminal sequence of the HCV genome. One gene in the upstream region, highly conserved by the two strains at the amino acid level and rich in basic amino acids such as arginine, appeared to encode the viral capsid protein. The other gene in the downstream region was divergent between the two strains at both nucleotide and amino acid levels. It coded for nine potential N-glycosylation sites, and was considered to encode the viral envelope protein. Disclosure of the 5'-terminal sequence of the HCV genome would facilitate its taxonomic classification, and contribute toward immunological diagnosis of infection and development of vaccines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170712

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  104 in total

1.  Approaches of the diagnosis of hepatitis viruses.

Authors:  G J Kotwal
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

2.  Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients.

Authors:  G J Kotwal; V K Rustgi; B M Baroudy
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

3.  Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance.

Authors:  S M Akbar; M Onji; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1992-08

4.  Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates.

Authors:  H Okamoto; N Kanai; S Mishiro
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

5.  Hepatitis C: a possible etiology for cryoglobulinaemia type II.

Authors:  A Pechère-Bertschi; L Perrin; P de Saussure; J J Widmann; E Giostra; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature.

Authors:  Mariacarmela Solmone; Enrico Girardi; Francesco Costa; Leopoldo Pucillo; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus.

Authors:  J T Wang; T H Wang; J C Sheu; S M Lin; J T Lin; D S Chen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

8.  Prevalence of hepatitis C virus infection in Nanjing, southern China.

Authors:  K Suzuki; M Mizokami; K Cao; X S Wu; R R Wu; A Hata; M Sasaki; Z X Fang; L Y Zhang; J Y Lau; S Iino
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

9.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by western blot (immunoblot) analysis using a recombinant vaccinia virus expression system.

Authors:  A Nishizono; M Hiraga; K Mifune; H Terao; T Fujioka; M Nasu; T Goto; J Misumi; M Moriyama; Y Arakawa
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.